According to GlobalData, QUADROX ID is one of 41 product lines sold in the US extracorporeal membrane oxygenation (ecmo) devices market; these product lines are sold by 10 different manufacturers. The average selling price for QUADROX ID decreased in hospitals, health systems, and outside of hospital facilities in 2022. The price of the QUADROX ID device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Getinge apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Getinge overview

Getinge AB (Getinge) is a medical technology company engaged in the designing, development and marketing of equipment and instruments in the areas related to surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators, and anesthesia equipments, heart-lung machines with accompanying disposables, equipments and instruments for cardiac surgery, vascular surgery; cardiac assist devices; patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipments, and documentation systems and various other accessories. The company also provides various services related to hospitals and project implementations. The company has manufacturing facilities in France, China, Germany, Poland, Sweden, Turkey, Netherlands, UK and the US and sells its products through proprietary sales companies and network of distributors in over 133 countries. Getinge is headquartered in Gothenburg, Sweden.

For a complete picture of QUADROX ID, Extracorporeal Membrane Oxygenation (ECMO) Devices pricing in the US, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.